Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron to Report Third Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2015


TARRYTOWN, N.Y., Oct. 8, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2015 financial and operating results on Wednesday, November 4, 2015, before the U.S. financial markets open.  The Company will host a conference call and...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q3 2015 Earnings Conference Call

11/04/15 at 8:30 AM ET

View Event

Form content here please :)